A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
NCT07218146
This study is recruiting at 37 US sites in 16 states, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this study is to evaluate the efficacy and safety of ZL-1310 compared to Investigator's Choice Therapy in participants with relapsed Small Cell Lung Cancer.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Small-cell Lung Cancer
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 3
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Zai Lab (Shanghai) Co., Ltd.
- Last updated on ClinicalTrials.gov
- September 14, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 2
- University of California San Diego · La Jolla, CA
- UC Davis Comprehensive Cancer Center · Sacramento, CA
Colorado · 1
- University of Colorado · Aurora, CO
Connecticut · 1
- Yale Cancer Center/Clinical Trials Office · New Haven, CT
Florida · 7
- Clermont Oncology Center · Clermont, FL
- Mid Florida Hematology and Oncology Center · Orange City, FL
- Cancer Centers of Bevard · Rockledge, FL
- Sarah Cannon Research Institute · Sarasota, FL
- Florida Cancer Specialists - North · St. Petersburg, FL
- Moffitt Cancer Center · Tampa, FL
- Florida Cancer Specialists - East · West Palm Beach, FL
Illinois · 2
- Illinois Cancer Care · Peoria, IL
- OSF St. Francis Medical Center · Peoria, IL
Iowa · 2
- University of Iowa · Iowa City, IA
- University of Iowa Mission Health Cancer + Blood · Waukee, IA
Kentucky · 1
- Norton Cancer Institute · Louisville, KY
Maryland · 2
- American Oncology Partners, PA - The Center for Cancer and Blood Disorders · Bethesda, MD
- Maryland Oncology Hematology · Silver Spring, MD
Michigan · 1
- Henry Ford Health Cancer · Detroit, MI
Missouri · 2
- Missouri Cancer Associates · Columbia, MO
- Mercy South · St Louis, MO
New York · 2
- Stony Brook Cancer Center · Stony Brook, NY
- Montefiore Medical Center · The Bronx, NY
Ohio · 5
- Cleveland Clinic - Akron General Medical Center · Akron, OH
- Cleveland Clinic · Cleveland, OH
- Cleveland Clinic - Fairview Hospital Molly Pavilion · Cleveland, OH
- University Hospitals Cleveland Medical Center · Cleveland, OH
- Cleveland Clinic - Hillcrest Hospital Cancer Center · Mayfield Heights, OH
Pennsylvania · 4
- Consultants in Medical Oncology and Hematology · Broomall, PA
- Alliance Cancer Specialists · Media, PA
- Allegheny General Hospital · Pittsburgh, PA
- University of Pittsburgh (UPMC) Hillman Cancer Center · Pittsburgh, PA
Tennessee · 1
- SCRI OP (Oncology Partners) · Nashville, TN
Texas · 3
- Texas Oncology - Central South · Austin, TX
- University of Texas Southwestern Medical Center/Clinical Research Department · Dallas, TX
- Texas Oncology - West Texas · Odessa, TX
Virginia · 1
- Virginia Cancer Specialists · Fairfax, VA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.